Amneal Pharmaceuticals Inc (NYSE:AMRX)
| 4.54 BATS BZX Real-Time Price As of 11:28am ET |  -0.13 / -2.78%Today’s Change | 2.40 Today|||52-Week Range 5.79 | -5.81% Year-to-Date |
Latest AMRX News | Press Releases
| Why Amneal (AMRX) is Poised to Beat Earnings Estimates Again Oct 22 / Zacks.com - Paid Partner Content | Is AMNEAL PHARMACEUTICALS, INC. (AMRX) Stock Outpacing Its Medical Peers This Year? Oct 20 / Zacks.com - Paid Partner Content |
| Aclaris (ACRS) Begins Phase II Study on Eczema Candidate Oct 21 / Zacks.com - Paid Partner Content | RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation Oct 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.67 |
| Today’s open | 4.59 |
| Day’s range | 4.41 - 4.67 |
| Volume | 501,840 |
| Average volume (3 months) | 1,186,774 |
| Market cap | $1.6B |
Data as of 11:28am ET, 10/28/2020
Growth & Valuation
| Earnings growth (last year) | -1,566.42% |
| Earnings growth (this year) | +69.29% |
| Earnings growth (next 5 years) | -3.00% |
| Revenue growth (last year) | -2.20% |
| P/E ratio | NM |
| Price/Sales | 0.39 |
| Price/Book | 3.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LGNDLigand Pharmaceutica... | +0.22 | +0.26% |
| ---- | ||
| ZEALZealand Pharma A/S | -0.03 | -0.09% |
| ARCTArcturus Therapeutic... | -2.73 | -5.20% |
Data as of 11:25am ET, 10/28/2020
Financials
| Next reporting date | November 6, 2020 |
| EPS forecast (this quarter) | $0.12 |
| Annual revenue (last year) | $1.6B |
| Annual profit (last year) | -$361.9M |
| Net profit margin | -22.25% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
